MCKESSON CORP
About MCKESSON CORP
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2026
- $403.4B
- Net income
- $4.8B
- Total assets
- $82.3B
- Market cap
- $93.2B
- Gross margin
- 3.6%
- Operating margin
- 1.5%
- Net margin
- 1.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $403.4B
- Cost of revenue
- $388.9B
- Gross profit
- $14.6B
- Operating expenses
- $8.3B
- Operating income
- $6.2B
- Income tax
- $1.1B
- Net income
- $5.1B
- EPS (basic)
- $38.55
- EPS (diluted)
- $38.38
Balance sheet
- Total assets
- $82.3B
- Current assets
- $57.2B
- Total liabilities
- $84.1B
- Current liabilities
- $67.0B
- Shareholders’ equity
- -$1.8B
Cash flow
- Operating cash flow
- $6.2B
- Investing cash flow
- -$3.4B
- Financing cash flow
- -$4.6B
- Net cash flow
- -$1.9B
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $93.2B
- P/E ratio
- 20.0
- EPS (diluted)
- $38.38
- Dividend yield
- 0.43%
- Shares outstanding
- 121.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 3, 1987
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $4.8B in FY2026.
- Revenue grew 53% from FY2022 to FY2026.
- Gross margin of 3.6%, net margin 1.3%.
- Trading 23% below its 52-week high.
- Pays a dividend yielding about 0.43% annually.
- Valued at a price-to-earnings (P/E) ratio of 20.0.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review MCKESSON CORP.
Write a review
News about MCKESSON CORP
News & sentiment via Polygon.io
